|
|
||||||||||||||
|
|
|||||||||||||||
Design
Randomised {allocation concealed*}
, blinded (outcome assessor and statistician),* placebo controlled trial with 12 months follow up.
Setting
23 primary care practices in North Staffordshire and South Cheshire, England.
Patients
164 patients who were 1870 years of age (66%
45 y, 52% men) and had consulted their general practitioner because they had had a new episode of lateral epicondylitis. Exclusion criteria were a history of inflam-matory arthritis or gross structural abnormality of the elbow, contraindications to non-steroidal anti-inflammatory drugs (NSAIDs) or local steroid injection, pregnancy, or breast feeding. 98% of patients were included in the analysis for 4 week complete recovery, 96% for 4 week and 12 month pain severity, and 98% for 6 month pain severity.
Intervention
Patients were allocated to a local corticosteroid injection of methylprednisolone, 20 mg, and 1% lignocaine, 0.5 ml (n=53); enteric coated naproxen, 500 mg twice daily for 2 weeks (n=53); or placebo for 2 weeks
Anthony S Dixon, MBChB
University of Hong Kong Hong Kong, China
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |